Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 127

1.

Lower incidence of Pneumocystis jirovecii pneumonia among Africans in the Netherlands host or environmental factors?

Schoffelen AF, van Lelyveld SF, Barth RE, Gras L, de Wolf F, Netea MG, Hoepelman AI; ATHENA national observational cohort study.

AIDS. 2013 Apr 24;27(7):1179-84. doi: 10.1097/QAD.0b013e32835e2c90.

PMID:
23276810
[PubMed - indexed for MEDLINE]
2.

Mortality predictors of Pneumocystis jirovecii pneumonia in human immunodeficiency virus-infected patients at presentation: Experience in a tertiary care hospital of northern Taiwan.

Wang HW, Lin CC, Kuo CF, Liu CP, Lee CM.

J Microbiol Immunol Infect. 2011 Aug;44(4):274-81. doi: 10.1016/j.jmii.2010.08.006. Epub 2011 Jan 20.

PMID:
21524964
[PubMed - indexed for MEDLINE]
3.

Risk of Kaposi sarcoma during the first months on combination antiretroviral therapy.

Lacombe JM, Boue F, Grabar S, Viget N, Gazaignes S, Lascaux-Cametz AS, Pacanowski J, Partisani M, Launay O, Matheron S, Rosenthal E, Rouveix E, Tattevin P, de Truchis P, Costagliola D, Goedert JJ.

AIDS. 2013 Feb 20;27(4):635-43. doi: 10.1097/QAD.0b013e32835cba6c.

PMID:
23196937
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Impact of antiretroviral therapy on tuberculosis incidence among HIV-positive patients in high-income countries.

HIV-CAUSAL Collaboration.

Clin Infect Dis. 2012 May;54(9):1364-72. doi: 10.1093/cid/cis203. Epub 2012 Mar 28.

PMID:
22460971
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

[HIV infection in immigrants in Spain: Epidemiological characteristics and clinical presentation in the CoRIS Cohort (2004-2006)].

Caro-Murillo AM, Gutiérrez F, Manuel Ramos J, Sobrino P, Miró JM, López-Cortés LF, Tural C, Moreno A, de Los Santos I, Murillas J, Camino X, Salavert M, Rubio R, Moreno S, del Amo J; CoRIS.

Enferm Infecc Microbiol Clin. 2009 Aug-Sep;27(7):380-8. doi: 10.1016/j.eimc.2008.10.007. Epub 2009 May 8. Spanish.

PMID:
19427080
[PubMed - indexed for MEDLINE]
6.

Retrospective review of Pneumocystis jirovecii pneumonia over two decades.

Travis J, Hart E, Helm J, Duncan T, Vilar J.

Int J STD AIDS. 2009 Mar;20(3):200-1. doi: 10.1258/ijsa.2008.008198.

PMID:
19255271
[PubMed - indexed for MEDLINE]
7.

Pneumocystis jirovecii pneumonia in patients with and without human immunodeficiency virus infection.

Su YS, Lu JJ, Perng CL, Chang FY.

J Microbiol Immunol Infect. 2008 Dec;41(6):478-82.

PMID:
19255691
[PubMed - indexed for MEDLINE]
8.

Pneumocystis carinii (jirovecii) pneumonia (PCP): the most common opportunistic infection observed in HIV/AIDS cases at the University Malaya Medical Centre, Kuala Lumpur, Malaysia.

Jamaiah I, Rohela M, Tok EL, Tan CL, Tan WH, Teo WS, Leow HF.

Southeast Asian J Trop Med Public Health. 2012 Jul;43(4):825-31.

PMID:
23077803
[PubMed - indexed for MEDLINE]
9.

Pneumocystis jirovecii pneumonia in African miners at autopsy.

Wong ML, Back P, Candy G, Nelson G, Murray J.

Int J Tuberc Lung Dis. 2006 Jul;10(7):756-60.

PMID:
16848337
[PubMed - indexed for MEDLINE]
10.

Program-level and contextual-level determinants of low-median CD4+ cell count in cohorts of persons initiating ART in eight sub-Saharan African countries.

Nash D, Wu Y, Elul B, Hoos D, El Sadr W; International Center for AIDS Care and Treatment Programs.

AIDS. 2011 Jul 31;25(12):1523-33. doi: 10.1097/QAD.0b013e32834811b2.

PMID:
21750418
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Clinicoepidemiological characteristics of HIV-infected immigrants attended at a tropical medicine referral unit.

Pérez-Molina JA, López-Vélez R, Navarro M, Pérez-Elías MJ, Moreno S.

J Travel Med. 2009 Jul-Aug;16(4):248-52. doi: 10.1111/j.1708-8305.2009.00308.x.

PMID:
19674264
[PubMed - indexed for MEDLINE]
12.

Differences in the clinical characteristics of Pneumocystis jirovecii pneumonia in immunocompromized patients with and without HIV infection.

Enomoto T, Azuma A, Kohno A, Kaneko K, Saito H, Kametaka M, Usuki J, Gemma A, Kudoh S, Nakamura S.

Respirology. 2010 Jan;15(1):126-31. doi: 10.1111/j.1440-1843.2009.01660.x. Epub 2009 Nov 23.

PMID:
19947989
[PubMed - indexed for MEDLINE]
13.

Virologic and immunologic response to highly active antiretroviral therapy in indigenous and nonindigenous HIV-1-infected patients in the Netherlands.

Nellen JF, Wit FW, De Wolf F, Jurriaans S, Lange JM, Prins JM.

J Acquir Immune Defic Syndr. 2004 Aug 1;36(4):943-50.

PMID:
15220701
[PubMed - indexed for MEDLINE]
14.

Use of the relationship between absolute lymphocyte count and CD4 count to improve earlier consideration of pneumocystis pneumonia in HIV-positive emergency department patients with pneumonia.

Napoli AM, Maughan B, Murray R, Maloy K, Milzman D.

J Emerg Med. 2013 Jan;44(1):28-35. doi: 10.1016/j.jemermed.2012.05.001. Epub 2012 Jul 21.

PMID:
22819682
[PubMed - indexed for MEDLINE]
15.

Discontinuation of Pneumocystis jirovecii pneumonia prophylaxis with CD4 count <200 cells/µL and virologic suppression: a systematic review.

Costiniuk CT, Fergusson DA, Doucette S, Angel JB.

PLoS One. 2011;6(12):e28570. doi: 10.1371/journal.pone.0028570. Epub 2011 Dec 16. Review.

PMID:
22194853
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Is it safe to discontinue primary Pneumocystis jiroveci pneumonia prophylaxis in patients with virologically suppressed HIV infection and a CD4 cell count <200 cells/microL?

Opportunistic Infections Project Team of the Collaboration of Observational HIV Epidemiological Research in Europe (COHERE), Mocroft A, Reiss P, Kirk O, Mussini C, Girardi E, Morlat P, Stephan C, De Wit S, Doerholt K, Ghosn J, Bucher HC, Lundgren JD, Chene G, Miro JM, Furrer H.

Clin Infect Dis. 2010 Sep 1;51(5):611-9. doi: 10.1086/655761. Erratum in: Clin Infect Dis. 2010 Nov 1;51(9):1114.

PMID:
20645862
[PubMed - indexed for MEDLINE]
Free Article
17.

Inequalities in HIV disease management and progression in migrants from Latin America and sub-Saharan Africa living in Spain.

Monge S, Alejos B, Dronda F, Del Romero J, Iribarren JA, Pulido F, Rubio R, Miró JM, Gutierrez F, Del Amo J; CoRIS.

HIV Med. 2013 May;14(5):273-83. doi: 10.1111/hiv.12001. Epub 2012 Nov 21. Erratum in: HIV Med. 2014 Jan;15(1):64.

PMID:
23171059
[PubMed - indexed for MEDLINE]
18.

HIV-associated Isospora belli infection: incidence and risk factors in the French Hospital Database on HIV.

Guiguet M, Furco A, Tattevin P, Costagliola D, Molina JM; French Hospital Database on HIV Clinical Epidemiology Group.

HIV Med. 2007 Mar;8(2):124-30.

PMID:
17352769
[PubMed - indexed for MEDLINE]
19.

Discontinuation of Pneumocystis carinii pneumonia prophylaxis after start of highly active antiretroviral therapy in HIV-1 infection. EuroSIDA Study Group.

Weverling GJ, Mocroft A, Ledergerber B, Kirk O, Gonzáles-Lahoz J, d'Arminio Monforte A, Proenca R, Phillips AN, Lundgren JD, Reiss P.

Lancet. 1999 Apr 17;353(9161):1293-8.

PMID:
10218526
[PubMed - indexed for MEDLINE]
20.

Low prevalence of Pneumocystis jirovecii lung colonization in Ugandan HIV-infected patients hospitalized with non-Pneumocystis pneumonia.

Taylor SM, Meshnick SR, Worodria W, Andama A, Davis JL, Cattamanchi A, den Boon S, Yoo SD, Goodman CD, Huang L; International HIV-associated Opportunistic Pneumonias (IHOP) Study.

Diagn Microbiol Infect Dis. 2012 Feb;72(2):139-43. doi: 10.1016/j.diagmicrobio.2011.10.009. Epub 2011 Dec 5.

PMID:
22153850
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk